Log In
BCIQ
Print this Print this
 

VXA-G1.1-NN

  Manage Alerts
Collapse Summary General Information
Company Vaxart Inc.
DescriptionOral adenoviral-vector based norovirus vaccine
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationNorovirus
Indication DetailsTreat norovirus gastroenteritis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today